National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.14694/EdBook_AM.2014.34.71PMID 24857062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Personalizing oncology: perspectives and prospects.

  2013cited by this paper
• Clinically Meaningful Responses to Sequential Gemcitabine-Based Chemotherapy Regimens in a Patient with Metastatic Pancreatic Cancer

  2013cited by this paper
• Precision oncology: an overview.

  2013cited by this paper
• Genome Sequencing Identifies a Basis for Everolimus Sensitivity

  2012cited by this paper

• Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical Overview

  2025cites this paper
• Transcriptomic Profiles and Functional Correlates of Cancer-Related Fatigue: A Cross-Sectional Study in Women Undergoing Cancer Treatment

  2025cites this paper
• Clinicopathological features and treatment outcomes of urothelial carcinoma variant histologies and non-urothelial bladder cancers

  2024cites this paper
• Topic: Precision Medicine Approaches in Cardiology: Personalized Therapies for Improved Patient Outcomes, a systematic review.

  2024cites this paper
• From N-of-one to series of exceptional responders: unlocking the mystery of outliers in oncology

  2023cites this paper
• Genomics-Driven Precision Medicine in Pediatric Solid Tumors

  2023cites this paper
• Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer Agents

  2023cites this paper
• Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association

  2023cites this paper
• A likely responder approach for the analysis of randomized controlled trials.

  2022cites this paper
• A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs

  2022cites this paper
• Perspectiva oncológica de la medicina de precisión y su implementación en pacientes pediátricos y adultos con genes de fusión NTRK: una visión para Colombia

  2022cites this paper
• Precision Medicine: A New Paradigm in Therapeutics

  2021cites this paper
• Starring role of Biomarkers and Anticancer Agents as a Major Driver in Precision Medicine of Cancer Therapy.

  2021cites this paper
• Can Systems Biology Advance Clinical Precision Oncology?

  2021cites this paper
• The Role of Hematopoietic Stem Cell Transplantation in CML

  2021cites this paper
• Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview

  2021cites this paper
• Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.

  2021cites this paper
• Psychosocial phenotyping as a personalization strategy for chronic disease self-management interventions.

  2021cites this paper
• Clustering of Cancer Attributed Networks by Dynamically and Jointly Factorizing Multi-Layer Graphs

  2021cites this paper
• Genome‐wide association study‐based deep learning for survival prediction

  2020cites this paper
• Basket trials: From tumour gnostic to tumour agnostic drug development.

  2020cites this paper
• Defining the Skin Cellular Community Using Single-Cell Genomics to Advance Precision Medicine.

  2020cites this paper
• Clinical Genetic Screening in Adult Patients with Kidney Disease.

  2020cites this paper
• Molecular Profiling of Exceptional Responders to Cancer Therapy.

  2020cites this paper
• Venom peptides in cancer therapy: An updated review on cellular and molecular aspects.

  2020cites this paper
• Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): a phase 2 study evaluating an individualized treatment strategy for metastatic disease.

  2020cites this paper
• Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries

  2020cites this paper
• The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review.

  2020cites this paper
• Genetic Algorithm based Convolutional Neural Network for Few Shot Learning in Disease type prediction on RNA-Seq Data

  2020cites this paper
• An overview of precision oncology basket and umbrella trials for clinicians

  2020cites this paper
• Complexity in Clinical Trials: Blind Spots, Misleading Criteria, Winners and Losers

  2020cites this paper
• Expression Levels of Therapeutic Targets as Indicators of Sensitivity to Targeted Therapeutics

  2019cites this paper
• 차세대 염기서열 분석법과 항암요법

  2019cites this paper
• Treatment sequencing in metastatic colorectal cancer.

  2019cites this paper
• New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.

  2019cites this paper
• Patient and Provider Perspectives Regarding Enrollment in Head and Neck Cancer Research

  2019cites this paper
• Preparing for The Era of Precision Medicine to Improve Individualized Outcomes in Women with Breast Cancer

  2019influential citation
• Geriatric pharmacotherapy: Appraising new drugs for neurologic disorders in older patients.

  2019cites this paper
• Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application

  2019cites this paper
• Difficulties and challenges in the development of precision medicine

  2019cites this paper
• Harnessing the Power of Collaboration and Training Within Clinical Data Science to Generate Real‐World Evidence in the Era of Precision Oncology

  2019cites this paper
• Impact of NCI-MATCH: a Nationwide Oncology Precision Medicine Trial

  2019cites this paper
• Exceptional Responders

  2019cites this paper
• Next generation sequencing and anti-cancer therapy

  2019cites this paper
• Defining, Identifying, and Understanding “Exceptional Responders” in Oncology Using the Tools of Precision Medicine

  2019cites this paper
• Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials

  2019cites this paper
• Precision Surgical Therapy for Adenocarcinoma of the Esophagus and Esophagogastric Junction.

  2019cites this paper
• Precision Cancer Medicine: Challenges and Opportunities

  2019cites this paper
• Current Activities of the Coalition of Cancer Cooperative Groups

  2019cites this paper
• Innovation in oncology clinical trial design.

  2019cites this paper
• Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.

  2018cites this paper
• High-throughput molecular techniques and personalized treatment for primary breast cancer

  2018cites this paper
• The emerging clinical relevance of genomics in cancer medicine

  2018cites this paper
• Precision oncology in the age of integrative genomics

  2018cites this paper
• Current Activities of the Coalition of Cancer Cooperative Groups.

  2018cites this paper
• Precision Medicine from a Public Health Perspective.

  2018cites this paper
• An emotional modulation model as signature for the identification of children developmental disorders

  2018cites this paper
• Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy

  2018cites this paper
• Emerging Opportunities for Target Discovery in Rare Cancers.

  2017cites this paper
• Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial

  2017cites this paper
• Diagnosis and treatment in the era of precision medicine – Precision medicine and tailor-made medicine

  2017cites this paper
• Communicating About Precision Oncology.

  2017cites this paper
• Precision Medicine for Heart Failure: Lessons From Oncology.

  2017cites this paper
• Challenges and methodology in the incorporation of biomarkers in cancer clinical trials.

  2017cites this paper
• Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.

  2017cites this paper
• Tissue-specific tumorigenesis: context matters

  2017cites this paper
• Scientific Advances in Thoracic Oncology 2016.

  2017cites this paper
• University of Birmingham Tracking the Evolution of Non-Small-Cell Lung Cancer

  2017cites this paper
• Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing Science

  2017cites this paper
• Tracking the Evolution of Non‐Small‐Cell Lung Cancer

  2017cites this paper
• Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement.

  2017cites this paper
• Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma.

  2017cites this paper
• Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy

  2017cites this paper
• Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma

  2017cites this paper
• [Medical imaging in tumor precision medicine: opportunities and challenges].

  2017cites this paper
• Precision medicine in pediatric oncology: Lessons learned and next steps

  2017cites this paper
• Moonshots and metastatic disease: the need for a multi-faceted approach when studying atypical responses

  2017cites this paper
• Enhanced antitumor effects and improved immune status of dendritic cell and cytokine-induced killer cell infusion in advanced cancer patients.

  2017cites this paper
• Diabète de type 2 : concilier Médecine de Précision et Primauté des Soins de Premier recours. Pas simple !: Quid du rôle des diabétologues et de l’hôpital ?

  2017cites this paper
• Precision Medicine: Progress, Pitfalls, and Promises

  2017cites this paper
• Clinical Impact of Hybrid Capture–Based Next‐Generation Sequencing on Changes in Treatment Decisions in Lung Cancer

  2017cites this paper
• Cancer predisposition syndromes: lessons for truly precision medicine

  2017cites this paper
• New challenges to psycho‐oncology research: Precision medicine oncology and targeted therapies

  2017cites this paper
• Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights

  2017cites this paper
• Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial

  2017cites this paper
• Precision medicine in pediatric oncology

  2017cites this paper
• Tracking the Evolution of Non-Small-Cell Lung Cancer

  2017cites this paper
• Precision Oncology and Genomically Guided Radiation Therapy, A Report From the ASTRO/AAPM/NCI Precision Medicine Conference

  2017cites this paper
• Development of a model to predict breast cancer survival using data from the National Cancer Data Base.

  2016cites this paper
• A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential – An Implication of Micropapillary Element -

  2016cites this paper
• The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China

  2016cites this paper
• Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH

  2016cites this paper
• New generation of breast cancer clinical trials implementing molecular profiling

  2016cites this paper
• NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

  2016cites this paper
• Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer

  2016cites this paper
• Future paradigms for precision oncology

  2016cites this paper
• Personalized prostate cancer care: from screening to treatment

  2016cites this paper
• Integrating cancer genomic data into electronic health records

  2016cites this paper
• The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care

  2016cites this paper
• Translating cancer genomes and transcriptomes for precision oncology

  2016cites this paper